BNP Paribas BNP recently reported solid results, reaffirming its bullish guidance for top-line growth and confirming a EUR 5 billion (7% of its current market value) share buyback. After incorporating ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

BNP Paribas (ENXTPA:BNP) posted revenue growth of 7.2% per year, outpacing the French market's 5.5% average, while earnings averaged 9.4% annual growth over the past five years. However, the most ...

Solid Q1 results and 2025 objectives confirmed. BNP recorded a low level of risk throughout the cycle. Expected growth in DPS and buyback (supportive news from ECB). Our buy rating is then confirmed.

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are ...

We increase our fair value estimate for BNP Paribas by 11% to EUR 85/share, which equals its net tangible book value at the end of 2023 and 9.5 times what we expect it to earn for 2023. We believe BNP ...

Sophis, a leading provider of cross-asset, front-to-back-office solutions, today announced that BNP Paribas Asset Management's (BNP PAM) Structured Investment division has chosen Sophis VALUE to help ...

Strong growth in all BNP divisions. Low cost of risk (even considering the negative one-off from Poland). Solid CET1 ratio and strong ROTE results. Based on tangible book value evolution, we slightly ...

B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic review ...